GE Healthcare, Merck Collaborating on Lung Imaging Tech Trial

May 05, 2008

NEW YORK (GenomeWeb News) – GE Healthcare said today it has signed an agreement giving the drugmaker Merck access to a molecular imaging agent GE is developing for high-speed, quantitative lung imaging.

The company said the collaborators will evaluate GE Healthcare’s Spin Signal Technology to determine if it can help researchers study the functioning of diseased lungs using modified xenon gas in conjunction with magnetic resonance imaging scans.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Cell Count

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

Varied Opinions

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

Marine Mammal Gene Loss

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

This Week in PNAS

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.

Main menu